Published in Respiration on January 22, 2014
Prognostic Factors on Malignant Pleural Effusion | NCT03276715
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax (2014) 2.36
Prognostic factors in patients with malignant pleural effusion. Respiration (2014) 1.09
Important prognostic factors for survival in patients with malignant pleural effusion. BMC Pulm Med (2015) 0.78
Authors' reply. Respiration (2014) 0.75
Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion. Medicine (Baltimore) (2016) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res (2006) 2.68
Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research. Int J Radiat Oncol Biol Phys (2006) 2.34
Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res (2003) 2.08
Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group. J Clin Oncol (2006) 1.74
Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys (2002) 1.74
Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis (2005) 1.71
Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma. Neoplasia (2005) 1.62
Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin. Melanoma Res (2003) 1.60
VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer. Lung Cancer (2004) 1.55
Acquired reactive perforating collagenosis: current status. J Dermatol (2010) 1.54
Global impairment of CD4+CD25+FOXP3+ regulatory T cells in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 1.51
Lactate dehydrogenase isoenzymes 1 and 5: differential expression by neoplastic and stromal cells in non-small cell lung cancer and other epithelial malignant tumors. Tumour Biol (2003) 1.47
Prognostic and predictive role of lactate dehydrogenase 5 expression in colorectal cancer patients treated with PTK787/ZK 222584 (vatalanib) antiangiogenic therapy. Clin Cancer Res (2011) 1.46
The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients. Med Oncol (2010) 1.45
Metastatic cancer cells from c-erbB-2 negative primary breast cancer maintain the original c-erbB-2/HIF1alpha phenotype. Cancer Biol Ther (2007) 1.38
Radiation-induced autophagy in normal and cancer cells: towards novel cytoprotection and radio-sensitization policies? Autophagy (2009) 1.38
Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet (2007) 1.34
LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am J Pathol (2010) 1.32
BNIP3 expression is linked with hypoxia-regulated protein expression and with poor prognosis in non-small cell lung cancer. Clin Cancer Res (2004) 1.31
c-erbB-2 related aggressiveness in breast cancer is hypoxia inducible factor-1alpha dependent. Clin Cancer Res (2004) 1.30
Serum and tissue LDH levels in patients with breast/gynaecological cancer and benign diseases. Gynecol Obstet Invest (2008) 1.30
Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer (2002) 1.27
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol (2003) 1.22
Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther (2003) 1.20
Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma. Cancer Biol Ther (2007) 1.18
"Autophagic flux" in normal mouse tissues: focus on endogenous LC3A processing. Autophagy (2011) 1.12
Lactate dehydrogenase 5 expression in squamous cell head and neck cancer relates to prognosis following radical or postoperative radiotherapy. Oncology (2009) 1.12
Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas. J Clin Pathol (2010) 1.11
Dermoid cyst in the hepatoduodenal ligament: report of a case. Surg Today (2008) 1.08
Clear cell sarcoma of the scapula. A case report and review of the literature. World J Surg Oncol (2006) 1.07
Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Sci (2006) 1.05
Neutrophil extracellular traps promote differentiation and function of fibroblasts. J Pathol (2014) 1.05
Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis. Gynecol Oncol (2006) 1.04
The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer. Gynecol Oncol (2008) 1.01
Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Sci (2006) 1.01
Hypoxia and activated VEGF/receptor pathway in multiple myeloma. Anticancer Res (2010) 0.99
Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol (2006) 0.99
Angiogenesis relates to estrogen receptor negativity, c-erbB-2 overexpression and early relapse in node-negative ductal carcinoma of the breast. Int J Surg Pathol (2003) 0.99
Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1. Melanoma Res (2011) 0.99
HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite. Blood (2007) 0.99
High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas. Gynecol Oncol (2011) 0.99
Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins. Leuk Lymphoma (2008) 0.98
Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse. Int J Cancer (2004) 0.97
Prognostic value of serum tumor markers in patients with lung cancer. Respiration (2002) 0.96
Vascular endothelial growth factor in inflammatory bowel disease. Int J Colorectal Dis (2003) 0.96
Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas. J Pathol (2002) 0.95
Pulmonary mucus gland adenomas: are they always of endobronchial localization? Case Rep Pathol (2013) 0.95
Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives. Crit Rev Oncol Hematol (2008) 0.94
Establishment and validation of a method for multi-dose irradiation of cells in 96-well microplates. Biochem Biophys Res Commun (2013) 0.93
Primary pleural lymphoma: plaque-like thickening of the pleura. Jpn J Radiol (2010) 0.93
Rare cases of primary pleural Hodgkin and non-Hodgkin lymphomas. Respiration (2008) 0.93
The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer. Cancer Biol Ther (2012) 0.93
Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study. Int J Radiat Oncol Biol Phys (2010) 0.92
The pathology of tumor stromatogenesis. Cancer Biol Ther (2007) 0.91
C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer. Lung Cancer (2006) 0.91
Phosphorylated KDR expression in endometrial cancer cells relates to HIF1alpha/VEGF pathway and unfavourable prognosis. Mod Pathol (2006) 0.91
Inclusion of vasculature-related variables in the Dukes staging system of colon cancer. Clin Cancer Res (2005) 0.90
Autophagy patterns and prognosis in uveal melanomas. Mod Pathol (2011) 0.90
Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): what is destined for the atypical endometrial hyperplasia? Autophagy (2011) 0.89
Sleepiness as a marker of glucose deregulation in obstructive sleep apnea. Sleep Breath (2011) 0.89
Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers Surg Med (2007) 0.89
The vascular network of tumours--what is it not for? J Pathol (2003) 0.89
Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1 alpha. Cancer Chemother Pharmacol (2003) 0.89
Recombinant tissue plasminogen activator in the treatment of pleural infections in adults. Respir Med (2008) 0.88
Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer. Clin Cancer Res (2002) 0.88
Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium. Cardiovasc Pathol (2007) 0.88
Immunohistochemical expression of metalloproteinases MMP-2 and MMP-9 in abdominal aortic aneurysms: correlation with symptoms and aortic diameter. Int J Mol Med (2003) 0.87
Expression of hypoxia-inducible factor (HIF)-1a-vascular endothelial growth factor (VEGF)-inhibitory growth factor (ING)-4- axis in sarcoidosis patients. BMC Res Notes (2012) 0.87
The pathogenesis of endometrial carcinomas at menopause: facts and figures. J Clin Pathol (2011) 0.87
Association of -634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery. Acta Obstet Gynecol Scand (2004) 0.87
Hypoxia-inducible factor-2 alpha (HIF-2 alpha) induces angiogenesis in breast carcinomas. Appl Immunohistochem Mol Morphol (2006) 0.86
Primary squamous cell carcinoma of the ampulla of Vater. JOP (2014) 0.86
Phase I/II trial of bevacizumab and radiotherapy for locally advanced inoperable colorectal cancer: vasculature-independent radiosensitizing effect of bevacizumab. Clin Cancer Res (2009) 0.86
The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIFI alpha/VEGF pre-treatment status? Anticancer Res (2003) 0.86
The angiogenetic effect of intramuscular administration of VEGF on muscle. The influence of exercise on angiogenesis. In Vivo (2005) 0.85
Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis. Respir Res (2009) 0.85
Hypofractionated accelerated radiotherapy with cytoprotection combined with trastuzumab, liposomal doxorubicine, and docetaxel in c-erbB-2-positive breast cancer. Am J Clin Oncol (2005) 0.85
Increased expression of epidermal growth factor receptor (EGF-R) in patients with different forms of lung fibrosis. Biomed Res Int (2013) 0.85
Node-related factors and survival in node-positive breast carcinomas. Breast (2005) 0.85
Carotid body tumor in a 13-year-old child: Case report and review of the literature. J Vasc Surg (2008) 0.85
Serum biomarkers in interstitial lung diseases. Respir Res (2005) 0.85
LC3A-positive "stone-like" structures in cutaneous squamous cell carcinomas. Am J Dermatopathol (2011) 0.84
Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway. Cancer Lett (2008) 0.84
"Stromatogenesis" and tumor progression. Int J Surg Pathol (2004) 0.84